1-2 of 2
Jenny Ye
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

Julio Rosenstock, Bruno Guerci, Markolf Hanefeld, Sandro Gentile, Ronnie Aronson, Francisco J. Tinahones, Christine Roy-Duval, Elisabeth Souhami, Marek Wardecki, Jenny Ye, Riccardo Perfetti, Simon Heller
Journal: Diabetes Care
Diabetes Care 2016;39(8):1318–1328
https://doi.org/10.2337/dc16-0014
Published: 23 May 2016
View article titled, Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial
Open the PDF for Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial in another window
Includes: Supplementary data
Journal Articles

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L)

Matthew C. Riddle, MD, Ronnie Aronson, MD, FRCPC, FACE, Philip Home, DPHIL, DM, FRCP, Michel Marre, MD, PHD, Elisabeth Niemoeller, MD, Patrick Miossec, MD, Lin Ping, MD, Jenny Ye, Julio Rosenstock, MD
Journal: Diabetes Care
Diabetes Care 2013;36(9):2489–2496
https://doi.org/10.2337/dc12-2454
Published: 13 August 2013
View article titled, Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: <subtitle>A 24-week, randomized, placebo-controlled comparison (GetGoal-L)</subtitle>
Open the PDF for Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: <subtitle>A 24-week, randomized, placebo-controlled comparison (GetGoal-L)</subtitle> in another window
Includes: Supplementary data